Eli Lilly is buying Verve Therapeutics, developer of gene-editing treatments for cardiovascular disease, for $1 billion plus ...

Discover the latest business news including rising gas prices, Zepbound shipments, At Home bankruptcy, and the Federal Reserve meeting.

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy. Eli Lilly ...

Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...

Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

The clinical trial underscores Innovent’s ambition to deliver innovative obesity treatment to patients across Asia.

SAN FRANCISCO and SUZHOU, China, June 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company tha ...

Lilly’s announcement Tuesday focused on single-dose vials for people paying out of pocket for the two lowest doses of Zepbound, priced at $399 and $549, and did not mention the savings-card ...

Experts say the drug can also be harmful if taken in large doses beyond its recommended ... like diphenhydramine—especially when newer options offer similar relief with fewer risks." ...

Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or ...